Life Sciences Directory

IST cube bildet eine Schnittstelle zwischen Wissenschaft und Finanzwelt und investiert in frühphasige, technologische Neugründungen sowie Life Science- und Tech-Start-ups aus dem akademischen Umfeld. IST cube hat seinen Sitz unmittelbar neben dem Campus des IST Austria in Klosterneuburg in Niederösterreich und eröffnet Gründer*innen damit Zugang zur Infrastruktur und zum Netzwerk einer weltweit renommierten und in Österreich einzigartigen Forschungseinrichtung.

We are an Office GMP Manufacturer that takes care of young and innovative Biotech Startups, to become independent and successful Health Care companies. Our main objective is to empower our clients to keep their investors satisfied and maintain their independence, by entering markets faster with their products. To achieve early market readiness, we provide our GMP-QMS platform, our expertise in product release and guideline-compliant software systems for effective document- and data management.

Karl Landsteiner University of Health Sciences (KL Krems) at Campus Krems offers a modern, demand-oriented education and continuing education in medicine and psychology as well as a PhD programme in Mental Health and Neuroscience. Research at KL Krems is marked by scientific collaboration between different departments from key fields of health sciences, medicine and psychology. The three university hospitals in Krems, St. Pölten and Tulln and the MedAustron Ion Therapy and Research Centre in Wiener Neustadt guarantee clinical teaching and research of the highest quality.

Karyon Biopharma Consulting e.U. supports clients during non-clinical drug development.

Services encompass:

• Design of product-tailored non-clinical development plans for medicinal products to enable CTA/IND (small molecules, biologics, ATMPs (cell- and vector-based), vaccines)

• Support in CRO selection and placement of studies at CROs (request for proposals for complex non-clinical programs, CRO comparisons up to placement and elaboration of detailed study plans)

• Involvement in study designs for non-GLP and GLP studies, monitoring and study report reviews, including data interpretation

• Support for regulatory questions: early regulatory strategy, preparation and conduct of regulatory interactions with regulatory Authorities, including coordination and moderation of Scientific Advice Meetings (national Authorities / EMA / FDA)

• Scientific writing of a broad range of (regulatory) documents, including non-clinical parts of Briefing Documents for Scientific Advice Meetings, IBs, non-clinical summaries and overviews of CTDs / INDs, non-clinical ATMP certification dossiers

• Preparation of different types of toxicological risk assessments / expert statements

• Preparation of biological evaluation reports (BERs) for substance-based medical devices

For further details, please contact me at a.guenzl@karyon-consulting.com

Kwizda Pharmadistribution is a leading Austria-based logistics service provider for the healthcare industry with deep pharma competence and market knowledge. Out of Vienna, we provide premium pre-wholesale services to the Austrian market and the CEE region. Our secondary packaging services focus on low-volume batch sizes and provide our clients with the additional supply chain flexibility they need to succeed. Contact us to get your logistics challenge solved!

Lignovations has developed a patented process to manufacture functional ingredients for cosmetics, coatings, packaging, and more from upcycled biomass. By transforming lignin, a component of biomass that protects the plant into so-called ‚Colloidal Lignin Particles’, Lignovations high-performance bio-material can replace non-renewable ingredients, such as UV filters, antioxidants, and emulsifiers that are harmful to human health and the environment.

Marinomed Biotech AG is a biopharmaceutical company focused on inventing, developing, and partnering clinically meaningful therapies for patients suffering from serious viral infectious diseases and autoreactive immune disorders. Since its foundation in 2006, Marinomed has launched two powerful technologies (Carragelose® and Marinosolv®) with promising product candidates in the pipeline and a great potential for developing drugs that target diseases with high unmet medical need.